Phase I trial of intraperitoneal paclitaxel combinated with mFOLFOX6 or CapeOX for colorectal cancer with peritoneal metastasis

ABSTRACT: Interventions: 20mg/m2 of weekly Intraperitoneal paclitaxel Primary outcome(s): Safety Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer With Peritoneal Metastasis

PROVIDER: 2638181 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR